Pagoclone

HCID 131664CAS 133737-32-3

기본 정보

표준 SMILES: CC(C)CCC(=O)CC1c2ccccc2C(=O)N1c1ccc2ccc(Cl)nc2n1
InChIKey: HIUPRQPBWVEQJJ-UHFFFAOYSA-N
분자식: C23H22ClN3O2
평균 분자량: 407.9 g/mol
단동위원소 질량: 407.1400546

이름 및 식별자

우선 이름: Pagoclone
IUPAC: 2-(7-chloro-1,8-naphthyridin-2-yl)-3-(5-methyl-2-oxohexyl)-3H-isoindol-1-one
영어명: Pagoclone
분자식: C23H22ClN3O2
분자량: 407.89

이름 및 동의어

Pagoclone133737-32-3IP 456PagoclonaRP 62955RP-62955IP-456CI-10432-(7-chloro-1,8-naphthyridin-2-yl)-3-(5-methyl-2-oxohexyl)-2,3-dihydro-1H-isoindol-1-one38VAG2SA33DTXSID40869830IP456

이름 더 보기

Pagoclone Labeled d42-(7-Chloro-2-naphthyridin-1,8-yl)-3-(5-methyl-2-oxohexyl)isoindolin-1-one2-(7-chloro-1,8-naphthyridine-2-yl)-3-(5-methyl-2-oxo-hexyl)-1-isoindolinone1H-Isoindol-1-one, 2-(7-chloro-1,8-naphthyridin-2-yl)-2,3-dihydro-3-(5-methyl-2-oxohexyl)-

RP62955pagoclonumRefChem:858293DTXCID908177402-(7-chloro-1.8-naphthyridin-2-yl)-2,3-dihydro-3-(5-methyl-2-oxohexyl)-1H-isoindol-1-one133737-48-1rac-Pagoclone2-(7-chloro-1,8-naphthyridin-2-yl)-3-(5-methyl-2-oxohexyl)isoindolin-1-one

데이터베이스 식별자

CAS: 133737-32-3、133737-48-1
PubChem CID: 131664
DTXSID: DTXSID40869830
ChEMBL: CHEMBL2104745
Nikkaji: J481.630G

물성

구조 계산 물성

XLogP: 4.6
극성 표면적: 63.2 Å²
수소 결합 공여자 수: 0
수소 결합 수용자 수: 4
회전 가능 결합 수: 6
무거운 원자 수: 29
형식 전하: 0
복잡도: 613

물리화학적 성질

녹는점: 173 · 173-179°C
저장 조건: -20 °C · -20°C Freezer
용해도: DMSO(약간 용해됨), 메탄올(약간 용해됨)
물리적 상태: 고체
색상: 옅은 주황색에서 옅은 빨간색까지

화학 및 산업

약리 정보

Pharmacodynamics · 1건

Pagoclone was originally developed as an anti-anxiety drug, but never commercialised. It is a partial agonist acting at GABAA receptors in the brain. In contrast to zopiclone, pagoclone produces anxiolytic effects with little or no sedative or amnestic actions at low doses.

Mechanism of Action · 1건

Pagoclone is a subtype-selective drug which binds primarily to the alpha2/alpha3 subtypes of the GABAA receptor which are responsible for the anti-anxiety effects of these kind of drugs, but has relatively little efficacy at the alpha1 subtype which produces the sedative and memory loss effects.